Total Funding
94
84
Total FundingVenture - Series Unknown raised
Growth Score
2 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
16981
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
Acquired by 
Lunai Bioworks
- Anne-Marie Carbonell: Co-Founder, Chief Executive Officer & Chief Medical OfficerPast Role: Karl Storz, Marketing Manager, Spine
- Catherine Park: Founder
About the Company
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet needs in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic
combinations.
It was founded in 2011 and is headquartered in Greenwich, Connecticut.
Women Founded
